Dostinex-Lite 0.5 - Beligas Pharmaceuticals

While primarily used for prolactin suppression, Cabergoline’s effects on dopamine receptors make it applicable in managing certain dopamine deficiency symptoms, such as those found in Parkinson’s disease. Though prolactin inhibition is its main therapeutic role, its capacity to stimulate dopamine pathways offers additional uses in neurological contexts. This dual functionality allows Cabergoline to serve patients with prolactin and dopamine imbalance, demonstrating its versatility as a therapeutic agent in both endocrine and neurological conditions​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Dostinex-Lite 0.5 by Beligas Pharmaceuticals, consult with your doctor or healthcare professional.